# FDA recall D-159-2013

> **Hospira Inc.** · Class II · drug recall initiated 2012-11-15.

## Product

Propofol Injectable Emulsion, 1%, packaged in a) 20 mL Single patient infusion vial, 200 mg/20 mL (10 mg/mL), NDC 0409-4699-30; b) 50 mL Single patient infusion vial, 500 mg/50 mL (10 mg/mL), NDC 0409-4699-33; c) 100 mL Single patient infusion vial, 1 g/100 mL (10 mg/mL), NDC 0409-4699-24; Rx only, Hospira, Inc., Lake Forest, IL 60045 USA

## Reason for recall

Presence of Particulate Matter: Visible particulate and particulate embedded in vials were observed during retain inspection.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-159-2013
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-11-15
- **Report date:** 2013-02-20
- **Termination date:** 2014-02-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-159-2013

## Citation

> AI Analytics. FDA recall D-159-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-159-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*